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Abstract Seventh-day Adventist (SDA) and non-SDA (21.3 and 78.7 %, respectively)
individuals (n = 7172) participating in the Complete Health Improvement Program, a
30-day diet and lifestyle intervention, in North America (241 programs, 2006–2012) were
assessed for changes in selected chronic disease risk factors: body mass index (BMI),
blood pressure (BP), pulse, lipid profile and fasting plasma glucose (FPG). Reductions
were greater among the non-SDA for BMI, pulse and blood lipids. Furthermore, the
majority of non-SDA in the highest risk classifications for BP, lipids and FPG, but only
some lipids among SDA, were able to show improvement by 20 % or more.
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Introduction
The burden from chronic disease is rising rapidly and represents one of the major health
challenges in the USA, with half of all deaths each year attributed to heart disease, stroke,
diabetes and cancer (CDC 2012). Chronic diseases also carry a major fiscal burden. The
direct (medical) and indirect (productivity) costs of cardiovascular disease alone are
projected to increase from $450 billion in 2010 to more than $1 trillion by 2030 (Hei-
denreich et al. 2011). The development of chronic disease has been strongly linked to
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lifestyle, particularly inappropriate dietary patterns and physical inactivity (Roberts and
Barnard 2005).
Research on the health of Seventh-day Adventists (SDA) since the 1950s has shown that
they appear to enjoy low rates of chronic diseases, resulting in lower total mortality,
despite living in areas where chronic diseases are prevalent (Willett 1999).
Who are the SDA?
While Seventh-Day Adventism has now become a worldwide religion with more than 18
million members, this conservative religious group was first organized as a denomination
in 1863 in the eastern USA (Fraser 2003; SDA 2014). In that same year, SDA also began to
emphasize the role of lifestyle in promoting health, happiness and enhanced spirituality
(Fraser 2003). While Adventists do not believe that good health practices are related to
religious virtue, they do believe that these choices are a valuable spiritual discipline (Fraser
2003); a tenet found in the Judeo-Christian belief system. In effect, Adventists recognize
the indivisible unity of body, mind and spirit, with the health of each component being so
integrated and interrelated that what affects one affects the functioning of the whole being.
Consequently, SDA health philosophy is built around the holistic biblical notion that the
human body is the temple of the Holy Spirit; therefore, it is to be cared for intelligently
(Fraser 2003). Along with adequate exercise and rest, Adventists are encouraged to adopt
the most healthful lifestyle, which includes a diet that is vegetarian but avoids caffeine-
containing beverages, rich and highly refined foods, hot condiments and spices, and
abstains from Biblically unclean foods, as well as alcohol, tobacco and narcotics (Fraser
2003). The dietary health laws found in Leviticus are the basis for Adventist health reform,
but the principles were expanded by Ellen White, the church’s primary health reformer,
commencing in 1863. In addition, as propounded by Bandura (2001), the social support
and knowledge derived from belonging to a group with similar values help members of the
SDA church adhere to the prescribed health behaviors that are not practiced by mainstream
society.
The Complete Health Improvement Program (CHIP)
The SDA church has placed great emphasis not only on traditional health care, but also on
education. It owns and runs more than 300 highly regarded hospitals and nursing homes/
retirement centers, as well as many clinics, dispensaries and orphanages around the world,
including the USA. Not only does the church promote its lifestyle prescriptions to its
members, but it is also active in delivering scientifically based health promotion and
lifestyle modification programs to the community. One such program is the Complete
Health Improvement Program (CHIP). CHIP, developed in 1986, is in harmony with the
prescriptive lifestyle of the SDA church and is based on scientific principles (Morton et al.
2013). It has been delivered by either health professionals or trained volunteers in various
workplaces, community and medical settings (Aldana et al. 2008; Diehl 1998; Englert et al.
2007; Morton et al. 2013). It has a strong educative component to change the participants’
attitudes toward healthy living, and health literacy around nutrition and health behaviors
has been shown to significantly improve as a result of the program (Aldana et al. 2008).
Participants are educated on the etiology of chronic disease and the benefits of positive
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lifestyle choices, with particular attention given to diet and physical activity. Sessions on
overcoming barriers to change, developing emotional intelligence and providing partici-
pants with strategies [self-monitoring, goal setting and problem solving (including
addressing unsupportive social and physical influences)] for behavior change maintenance,
in an environment that provides social support, are also included. The CHIP sessions were
structured around a process of learn, experience, reflect. The use of the supplied resources
means that the program delivery is consistent in each location.
CHIP has been demonstrated to achieve meaningful reductions in selected risk factors—
body mass index (BMI), blood pressure (BP), total cholesterol (TC), low-density
lipoprotein (LDL), triglycerides (TG) and fasting plasma glucose (FPG)—for cardiovas-
cular disease and type 2 diabetes mellitus among large cohorts from several countries
including the USA (Aldana et al. 2008; Diehl 1998; Englert et al. 2007; Morton et al.
2013).
There have been no studies that have explored whether non-SDA can achieve improved
health outcomes comparable to SDA following an intensive lifestyle intervention delivered
in a Christian setting, with supportive religious community. Given their beliefs on health
and that SDA have lower rates of disease than the general population, it is expected that
they would have less at-risk biometrics than non-SDA at the commencement of such an
intervention. Further, given that SDA should have lower risk factors for chronic disease, it
is expected non-SDA would make greater improvements in their risk factors than SDA.
The aim of the present study was to examine whether the faith-based intervention, CHIP,




The CHIP intervention previously described in detail (Aldana et al. 2008; Diehl 1998;
Englert et al. 2007; Morton et al. 2013) was delivered to 7166 participants, who had self-
selected to participate in the program between January 2006 and September 2012. A total
of 241 CHIP interventions (mean group size 30, range 1–203) were conducted at 163
venues throughout North America over this period. There were no inclusion/exclusion
criteria other than the participant being able to pay a $200 program cost. By comparison,
weight loss diets typically cost more than this per annum (ABC 2014). Participants were
invited to attend the intervention through word of mouth invitation, local media avenues
and referrals from healthcare providers. As indicated by baseline characteristics (Tables 1
and 2), the participants comprised a more at-risk and ill demographic compared to the
general North American population (CDC 2014a, WCIN 2014). The (name of the ethics
committee removed for blinding) Ethics Committee (IRB) approved the study.
Facilitator Information
The CHIP programs were conducted by volunteer facilitators, sourced primarily through
the Seventh-day Adventist Church, who had an interest in positively influencing the health
of their local community. All volunteers were required to undergo 2 days of training to
learn about the CHIP intervention and develop group facilitation skills. There were no
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educational requirements or selection criteria for the volunteer facilitators. The educational
component of the CHIP intervention was presented through the pre-recorded videos. The
role of the volunteer facilitator was to organize the meetings and facilitate discussion.
Description of CHIP
The CHIP intervention involved 16 group sessions conducted in a community setting over
30 days (Diehl 1998; Englert et al. 2007). The program encourages and supports partici-
pants to move toward a low-fat (\15 % of calories from fat), ad libitum plant-based diet
over 30 days, with emphasis on the daily whole-food consumption of grains, legumes,
fruits and vegetables and water (2–2.5 L), while limiting intake of added sugar, sodium and
cholesterol (40 g, 2000 and 50 mg, respectively). This eating style is high in nutrient
density and fiber yet low in energy density. In addition, the program advocates that par-
ticipants engage in 30 min of moderate physical activity daily (walking) and practice stress
management techniques (life balance, sleep, rest).
Each of the 16 group sessions, delivered 4 days per week for 30 days, was approxi-
mately 1 h in duration, with approximately half of the session involving the viewing of a
pre-recorded educational video and the other half constituting group activities, such as
cooking demonstrations, physical exercises and discussion. Participants were deemed to
have completed the intervention if they attended a minimum of 13 of the 16 sessions and
completed the baseline and 30-day assessments. This number of sessions was set so as to
equate to more than 80 % of the program. Following completion, participants were invited
to attend ongoing monthly follow-up sessions to reinforce lifestyle behavior changes and
build a network of support and ongoing education. For a discussion on the development
and detailed description of the CHIP program, the reader is referred to the review article by
Morton et al. (2014).





Test statistic p value
Male 1881 33.3 % 513 33.7 % V2(1) = 0.071 0.790
Age 5643 57.4 ± 12.8 1521 57.5 ± 13.8 t(2276) = -0.387 0.699
Married 3493 73.7 % 1121 75.5 % V2(3) = 5.896 0.117
Smoker 133 0.6 % 9 2.6 % V2(4) = 96.74 \0.001
Weight (lb) 5132 194.7 ± 50.2 1365 186.3 ± 51.5 t(6495) = 5.470 \0.001
BMI (kg/m2) 5127 31.48 ± 7.42 1363 30.10 ± 7.39 t(6488) = 6.103 \0.001
SBP (mm Hg) 5088 133.8 ± 19.1 1364 132.4 ± 19.3 t(6450) = 2.292 0.022
DBP (mm Hg) 5084 79.91 ± 11.41 1366 79.28 ± 11.57 t(6448) = 1.785 0.074
TC (mg/dL) 5218 193.2 ± 41.9 1400 190.4 ± 41.0 t(6616) = 2.264 0.023
LDL (mg/dL) 5090 116.7 ± 35.5 1378 114.5 ± 35.6 t(6466) = 2.245 0.041
HDL (mg/dL) 5214 49.20 ± 15.28 1400 48.10 ± 13.55 t(2442) = 2.604 0.009
TC:HDL ratio 5212 4.215 ± 1.372 1400 4.224 ± 1.400 t(6610) = -0.225 0.822
TG (mg/dL) 5206 142.9 ± 89.0 1399 143.4 ± 89.7 t(6603) = -0.165 0.869
FPG (mg/dL) 5181 102.9 ± 30.7 1381 97.78 ± 26.41 t(2470) = 6.146 \0.001
Pulse (beats/min) 4970 71.71 ± 11.01 1335 70.65 ± 10.67 t(6303) = 3.147 0.002






























































































































































































































































































































































































































































































































































































































































































































































































































































































J Relig Health (2016) 55:1561–1573 1565
123
Data Collection and Reporting
Before participating in the CHIP intervention (baseline) and again at its conclusion
(post-intervention), the participants’ height, weight, SBP and DBP were taken and
fasting (12-h) blood samples were collected by registered health professionals. The
same scales and sphygmomanometer were used for taking measurements at baseline
and again at 30 days. The blood samples were collected by trained phlebotomists and
analyzed by local pathology laboratories for TC, LDL, HDL, TG and FPG levels. Self-
report health conditions were also collected at baseline but not at follow-up. Biometric
data were not collected following the 30-day assessment, and so evaluation of the
biometric outcomes during the follow-up sessions is beyond the scope of the current
study.
Statistical Analysis
The data were analyzed using IBMTM Statistics (version 19) and expressed as
mean ± SD. The extent of the changes (from baseline to post-intervention) in the
biometric measures was assessed for non-SDA and SDA separately, using paired t tests.
Cohen’s d was determined to examine the size of the difference between non-SDA and
SDA. One-way between-groups analysis of covariance was also conducted to compare
the effectiveness of the intervention between SDA and non-SDA, with the relevant
baseline biometric, smoking status and the usual demographic variables age, gender and
marital status used as covariates. About 7 % of non-SDA and SDA (N = 376 and 114,
respectively) did not have follow-up data for some or all biometrics at 30 days, hence
the variation in the number (n) listed in Table 1 between the biometrics. The McNemar
Chi-square test was used to determine the changes in the distribution of participants by
SDA status, across the various risk factor categories. Participants’ weight was char-
acterized into risk categories using standard BMI cut points for ‘‘normal,’’ ‘‘over-
weight’’ and ‘‘obese’’ (NHLBI 2013), BP was classified using the 5th Joint National
Committee for Hypertension guidelines (JNC 1993), and FPG was characterized
according to conventional ‘‘normal,’’ ‘‘impaired’’ and ‘‘diabetic’’ levels (NCEP 2002).
The National Cholesterol Education Program Adult Treatment Panel III (ATP III)
classification system (NCEP 2002) was used to categorize the participants for all risk
factors, except total cholesterol, for which the Framingham risk classification (Wilson
et al. 1998) was used. The Framingham classification includes five cholesterol cate-
gories compared to only three in the ATP III classification system and thus allowed a
more detailed analysis of the effect of the intervention on the highest risk participants.
Metabolic syndrome at baseline and after intervention was classified according to the
‘‘harmonized definition’’ (Alberti et al. 2009). Participants were deemed as having this
syndrome if they met three or more of the defining criteria (Alberti et al. 2009). A
P value of less than 0.05 was considered significant. Confidence intervals (95 %) are
also presented. In order to reduce the type 1 error that can occur when simultaneous
tests are performed in a data set which is split into risk categories, a Bonferroni
correction was applied to each biometric separately. As there were a different number
of risk category comparisons for each biometric, the correction applied was 0.05/n,
where n was the number of categories within each biometric. Participants that did not
have baseline biometrics were removed.
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Results
Of the 7172 participants, 21.3 % (n = 1523) were SDA and 78.7 % (n = 5643) were non-
SDA. There was no difference between SDA and non-SDA in the distribution of men and
women, age or the proportion reported being married. More non-SDA than SDA reported
smoking at baseline (Table 1). In terms of baseline biometrics, both non-SDA and SDA
were representative of an at-risk population with a mean BMI in the ‘‘obese’’ category and
elevated SBP and LDL. Even so, non-SDA had higher mean baseline weight, BMI, TC,
LDL, HDL, FPG and pulse rate (Table 1). However, the effect size for these differences
was very small to small (Cohen’s d range, 0.06–0.19). There were no differences between
SDA and non-SDA in mean baseline DBP, TG and TC:HDL ratio.
Non-SDA achieved greater reductions in weight, BMI, TC, LDL and HDL following
the intervention, but SDA achieved greater changes in SBP and pulse rate (Table 2).
Again, the effect sizes for these differences were only small (Cohen’s d range 0.01–0.16).
However, there were no differences in changes in DBP, TG, TC:HDL ratio and FPG
between non-SDA and SDA (Table 2). The proportion of non-SDA and SDA classified
with the metabolic syndrome at baseline decreased significantly at 30 days (non-SDA
44.4–38.1 %, V2(1) = 1973.0, p\ 0.001; SDA 40.0–31.7 %, V2(1) = 518.4, p\ 0.001).
Stratification of risk factors showed substantive changes in the distribution of non-SDA
and SDA across the various categories, with the largest reductions among participants with
the highest risk classifications at baseline (Table 3). Furthermore, while statistical analysis
could not be performed for the proportional reduction in non-SDA compared to SDA in
each risk category examined separately, more non-SDA than SDA presenting with the
highest category for SBP ([160 mmHg), DBP ([100 mmHg), TG ([500 mg/dL) and
diabetes ([500 mg/dL) reduced their risk characterization at 30 days (66 vs. 58 %, 77 vs.
52 %, 75 vs. 70 %, 42 vs. 34 %, respectively) (Table 3). Conversely, in the highest risk
category for LDL (C190 mg/dL), more SDA than non-SDA (82 vs. 67 %, respectively)
were no longer in this risk category (Table 3).
An analysis of mean changes in the various biometric categories also indicated that non-
SDA tended to achieve greater improvements than the SDA. In just 30 days, the majority
of non-SDA in the highest risk classifications for DBP, TC, LDL, TG and FPG, but only
LDL and TG for SDA were able to show improvement by 20 % or more (Table 3).
Discussion
Substantial reductions in selected risk factors were achieved in 30 days using the CHIP
lifestyle intervention for both SDA and non-SDA, but the reductions were greater for BMI,
pulse and blood lipids among non-SDA. These differences go beyond higher baseline
levels in non-SDA. Furthermore, in 30 days, the majority of non-SDA in the highest risk
classifications for DBP, TC, LDL, TG and FPG, but only LDL and TG for SDA were able
to show improvement by 20 % or more. A seemingly adverse outcome of the CHIP
intervention is the reduction in HDL among both non-SDA and SDA, which has also been
observed in other lifestyle interventions that promote a plant-based eating pattern (Ornish
et al. 1998). However, this reduction in HDL is not considered detrimental to the risk of
chronic disease when a whole-food plant-based diet is adopted, as discussed by Kent et al.
(2013b).
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National estimates of mean body weight and BMI for the USA, 1999–2002, are lower
than that of the sample of non-SDA in this study (Ogden et al. 2004). Indeed, 82 % of the
non-SDA in this study was classified as overweight or obese, while 64 % of the US
population was classified as such in 1999–2000 and 69 % in 2011–2012 (CDC and
NHANES 2003; CDC 2013). Non-SDA participants in this study faired more positively in
terms of the proportion with cholesterol levels[200 mg/dl and LDL levels[130 mg/dl
compared to the general US population (Go et al. 2014). However, a greater proportion of
non-SDA participants in this study were characterized with diabetes than the 2012 general
US population (CDC 2014b).
Compared to SDA in the Adventist Health Study-2, the SDA in the present study were
slightly younger (60.3 vs. 57.7 years) and had higher BMI (28.2 vs. 30.1 kg/m2), total
cholesterol (188.3 vs. 190.2 mg/dl), triglycerides (123.5 vs. 143.3 mg/dl) and FPG (95.6
vs. 97.8 mg/dl) (Professor Gary Fraser, Chief Investigator, AHS-2, personal communica-
tion). As a group, SDA have traditionally enjoyed lower rates of many diseases, including
obesity, CVD and diabetes than the general population because of their prescriptive life-
style. This may explain their lower baseline biometrics compared to non-SDA as they were
likely following elements of the CHIP intervention before the program commenced. Given
this, it is surprising that the differences between SDA and non-SDA at baseline were not
greater. However, it should be noted that the CHIP program targets individuals with
established risk factors for chronic disease, so those attending would not be representative
of the wider church.
Notwithstanding the greater reductions among non-SDA, SDA did achieve substantial
risk reductions for most biometrics. More than 50 % of non-SDA and SDA with higher
baseline risk levels for SBP, TC, LDL and TG reduced their risk characterization after the
30-day intervention. The changes in TC and LDL levels compare favorably to those
achieved by pharmaceutical interventions involving statins (Gould et al. 2007), but without
the risk, and are much greater than that expected from dietary interventions aimed at
lowering blood lipids (Tang et al. 1998). Furthermore, almost half of non-SDA and one-
third of SDA characterized with diabetes reduced this characterization. Of note, risk factor
characterization of all biometrics was reduced to at least the next lower level for both non-
SDA and SDA, but more so for non-SDA, with some participants reducing two or three
levels, particularly if they were in the higher risk categories at baseline. As a result, the
amount of change between non-SDA and SDA in the highest baseline levels for BMI,
DBP, TC, TG and FPG may not have reached significance because of the small numbers
remaining in these risk categories at 30 days.
The relationship between religiosity/spirituality (RS) and health outcomes is still being
explored in the literature. Chida et al. (2009) found a lack of association between RS and
mortality in people with severe illness, suggesting that the individual’s RS or decreasing
RS activity over the years may dilute the effect of RS on health. This may explain why
SDA in this study entered the CHIP program with higher biometric risk factors compared
to AHS participants who are representative of the US SDA population as a whole. A recent
Australian study found that while SDA consumed more health-promoting foods and less
processed foods than non-SDA, the gap between SDA and non-SDA food consumption
patterns decreased between 1976 and 2005, possibly due to the ‘secularization’ of the
participants (Kent and Worsley 2008).
Interestingly, the protective effect on mortality of Christian church activity or atten-
dance has been found to be quite similar to that of organizational activity in general,
suggesting that this effect may not be restricted to Christian faiths alone (Chida et al.
2009). The content of the CHIP program does not include any RS material nor SDA
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propaganda. Rather up to date, scientific information on the prevention and treatment of
chronic disease is provided in a socially inclusive and supportive environment. In light of
the supportive SDA church environment, Fraser (2003) reported that ‘‘when the group
culture supports a belief in clear benefits, defines standards of behavior, and then provides
skills and opportunities to improve self-efficacy, success becomes more likely. The per-
ception that one’s performance is being observed and compared with community values
may be motivating. The teaching of the necessary skills becomes easier when one belongs
to a supportive and focused society.’’ This observation may apply to not only supporters
and regular attendees of the SDA church but also individuals who engage in programs
within the supportive church environment. The ability of the SDA community to not
restrict health and community programs to its own members, and even more so, that non-
SDA would accept an invitation to a faith-based program, is noteworthy. Despite the strong
positive outcomes achieved by following the CHIP intervention, a strength of this program
is that all members of the wider community can meet together and gain the social support
needed to experience the benefits.
Limitations
As the participants were self-selected, they likely entered the program with an elevated
readiness for change and hence willingness to engage in the intervention (Norcross et al. 2011).
The generalizability of the findings to less motivated populations needs to be determined. A
further limitation was the short follow-up time after which the benefits gained by both groups
may have been lost. A small New Zealand study found that 106 CHIP participants who returned
for follow-up assessment, on average 4 years after completion of the intervention, were able to
maintain improvements in most of their biometrics (Kent et al. 2013a). Furthermore, 71 % of
participants reported that they were still compliant to the CHIP principles after this time, but it
was not clear how this differed for non-SDA and SDA in this preliminary study of only 1 month.
As duration of the intervention effects and their costs–benefits, especially in comparison with
non-intervention groups, is of key interest to health promoters, the CHIP intervention should be
extended, for periods such as 6 months to 5 years.
Information on diet and physical activity was not collected in this study. Similarly,
program compliance data were not collected, and, while the biometric changes suggest
participants changed their health behaviors, the extent to which this occurred is unknown.
Presumably, the participants entered the program with different health behaviors and made
varying degrees of change throughout the intervention. A further limitation of this study
was that SDA beliefs and attitudes toward the church’s health philosophy, to gauge ‘im-
munity’ to the secular effects of changes to societal norms and attitudes to health-pro-
moting behaviors, were not collected. Nor was information about non-SDA’s religious
beliefs and attitudes toward health in general in this data set. The non-SDA in this data set
may have had similar attitudes toward health as SDA, hence their readiness to change their
behaviors when provided with the opportunity, knowledge, support and skills to do so. In
addition, measures of social support and their relative importance to SDA and non-SDA
were not collected in this study. Future studies should gather valid measures of psy-
chosocial factors, including RS, as well as various lifestyle changes made by participants
during the CHIP program to elucidate their contribution to the results achieved.
Another limitation is that medication changes and how this differed between SDA and
non-SDA were not recorded. Several anecdotal reports from participants in this study
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indicated that personal physicians decreased doses or even discontinued participants’
medications (e.g., for hypertension, hypercholesterolemia or hyperglycemia) during the
30 days of the intervention. While this is a desirable outcome, reduced medication usage
may have caused the results to be understated and to vary between SDA and non-SDA.
Further studies are in process to explore the influence of these factors on the outcomes
achieved in the program. Despite the limitations in the research design, the current study
results are noteworthy, given the size of the sample and the effects observed.
Conclusion
The CHIP program effectively reduced chronic disease risk factors among both SDA and
non-SDA, but more so among non-SDA for many biometrics, with the largest reductions
occurring in individuals at greatest risk. This indicates that SDA do not have a monopoly
on good health and that positive health outcomes can be achieved by members of the wider
community attending this faith-based intervention.
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